Difference between revisions of "Ordonez-Moran P, et al. Cancer Cell (2015) cited as Ref 159 in DOI: 10.1038/s41392-020-0110-5 (Q9422)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 815-829, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fifth Author string (P153): Huelsken J, #quickstatements; #temporary_batch_1590155508986) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / Fourth Author string | |||
| + | Nishida E | ||
| Property / Fourth Author string: Nishida E / rank | |||
| + | Normal rank | ||
| Property / Fifth Author string | |||
| + | Huelsken J | ||
| Property / Fifth Author string: Huelsken J / rank | |||
| + | Normal rank | ||
Latest revision as of 13:52, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Ordonez-Moran P, et al. Cancer Cell (2015) cited as Ref 159 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Ordonez-Moran P
0 references
Dafflon C
0 references
Imajo M
0 references
2015
0 references
Cancer Cell
0 references
28
0 references
HOXA5 counteracts stem cell traits by inhibiting Wnt signaling in colorectal cancer (English)
0 references
815-829
0 references
Nishida E
0 references
Huelsken J
0 references
